ECONOMIC BURDEN OF CANCER CARE IN LOW AND MIDDLE-INCOME COUNTRIES: CAN MEDICINAL PLANTS PROVIDE RELIEF?

Cancer poses a significant public health challenge worldwide, with low and middle-income countries (LMICs) bearing a disproportionate burden. The economic impact of cancer care in these regions is profound, straining already limited healthcare resources and leading to high out-of-pocket expenditures for patients and their families. The study explores the potential role of medicinal plants as a cost-effective and accessible alternative or complement to conventional cancer therapies in LMICs. We analyze the economic burden of cancer care, highlight the financial challenges faced by LMICs, and examine the therapeutic potential of medicinal plants. Evidence from various studies indicates that medicinal plants can offer affordable and culturally accepted treatment options, potentially reducing the economic strain on healthcare systems and patients. The integration of medicinal plants into cancer care strategies could improve access to treatment, enhance patient outcomes, and provide sustainable solutions to the escalating costs of cancer care in LMICs. Further research and policy support are needed to validate these benefits and facilitate the incorporation of medicinal plants into mainstream cancer treatment protocols.